Evidence map›Paper›PMID 39258538›Full record

ArticleNucleic acids research2024

A single rare σ70 variant establishes a unique gene expression pattern in the E. coli pathobiont LF82.

Melissa Arroyo-Mendoza, Alexandra Proctor, Abraham Correa-Medina, Sarah DeWolf, Meghan Wymore Brand, Virginia Rosas, Hernan Lorenzi, Michael J Wannemuehler, Gregory J Phillips, Deborah M Hinton

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Journal of bacteriology · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melissa Arroyo-MendozaGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 8 Center Dr., Bethesda, MD, USA.
Alexandra ProctorDepartment of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Abraham Correa-MedinaGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 8 Center Dr., Bethesda, MD, USA.
Sarah DeWolfDepartment of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Meghan Wymore BrandDepartment of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Virginia RosasGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 8 Center Dr., Bethesda, MD, USA.
Hernan LorenziTriLab Bioinformatics Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 8 Center Dr., Bethesda, MD, USA.
Michael J WannemuehlerDepartment of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Gregory J PhillipsDepartment of Veterinary Microbiology and Preventative Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Deborah M HintonGene Expression and Regulation Section, Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 8 Center Dr., Bethesda, MD, USA.ORCID 0000-0002-7254-9495

Funding

Highly simplified model of a mammalian intestinal communityR01GM099537 · NIGMS · IOWA STATE UNIVERSITY · PI PHILLIPS, JAMES GREGORY · 2013 to 2016
$1.0M
Microbiome Dynamics During Cancer ProgressionR03CA195305 · NCI · IOWA STATE UNIVERSITY · PI PHILLIPS, JAMES GREGORY · 2017 to 2018
$142k
Defense Threat Reduction Agency HDTRA12110015NCI NIH HHS R03 CA195305NIGMS NIH HHS R01 GM099537NIH HHS R01 GM099537
6 · The paper itself

Abstract

LF82, an adherent-invasive Escherichia coli (AIEC) pathobiont, is associated with Crohn's disease, an inflammatory bowel disease of unknown etiology. Although AIEC phenotypes differ from those of 'commensal' or pathogenic E. coli, work has failed to identify genetic features accounting for these differences. We have investigated a natural, but rare, single nucleotide polymorphism (SNP) in LF82 present within the highly conserved rpoD gene, encoding σ70 [primary sigma factor, RNA polymerase (RNAP)]. We demonstrate that σ70 D445V results in transcriptomic and phenotypic changes consistent with LF82 phenotypes, including increased antibiotic resistance and biofilm formation and increased capacity for methionine biosynthesis. RNA-seq analyses comparing σ70 V445 versus σ70 D445 identified 24 genes upregulated by σ70 V445 in both LF82 and the laboratory E. coli K-12 strain MG1655. Using in vitro transcription, we demonstrate that σ70 D445V directly increases transcription from promoters for several of the up-regulated genes and that the presence of a 16 bp spacer and -14 G:C is associated with this increase. The position of D445V within RNAP suggests that it could affect RNAP/spacer interaction. Our work represents the first identification of a distinguishing SNP for this pathobiont and suggests an underrecognized mechanism by which pathobionts and strain variants can emerge.

Indexed as

Escherichia coliGene Expression Regulation, BacterialPolymorphism, Single NucleotideSigma FactorBiofilmsCrohn DiseaseDNA-Directed RNA PolymerasesEscherichia coli ProteinsHumansPromoter Regions, GeneticTranscription, GeneticTranscriptomeDNA-Directed RNA PolymerasesEscherichia coli ProteinsRNA polymerase sigma 70Sigma Factor

Identifiers

PMID39258538
PMCPMC11514462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.